Korean J Clin Microbiol.
2007 Oct;10(2):171-172.
In vitro Susceptibility of Imipenem-resistant Pseudomonas aeruginosa against Piperacillin/tazobactam
- Affiliations
-
- 1Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea. euichong@snu.ac.kr
Abstract
- Minimal inhibitory concentrations (MICs) against piperacillin/tazobactam were determined on a total of 50 clinical isolates of imipenem resistant Pseudomonas aeruginosa (IRPA). MIC50 and MIC90 were 32microgram/mL and 512microgram/mL, respectively. The susceptibility of IRPA against piperacillin/tazobactam was 59%. Of the 50 IRPA strains, only two were PCR positive for blaVIM and none for blaIMP.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- In-Vitro Efficacy of Synergistic Antibiotic Combinations in Multidrug Resistant Pseudomonas Aeruginosa Strains
- Antimicrobial Resistance Surveillance of Bacteria in 1999 in Korea with a Special Reference to Resistance of Enterococci to Vancomycin and Gram-Negative Bacilli to Third Generation Cephalosporin, Imipenem, and Fluoroquinolone
- Antimicrobial Susceptibility and Clonal Distribution of the Blood Isolates of Pseudomonas aeruginosa from Two Korean Hospitals
- In Vitro Effects of Combined Antibiotics against Multidrug-resistant Pseudomonas aeruginosa
- Susceptibility of Clinical Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa to Colistin and Polymyxin B in Korea
